Test ID RPRT Rapid Plasma Reagin (RPR), Response to Therapy, Serum
Useful For
Determining the current disease status and evaluating response to therapy for syphilis
Method Name
Flocculation
Reporting Name
RPR, Response to Therapy, SSpecimen Type
SerumContainer/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Refrigerated (preferred) | 14 days |
Frozen | 14 days |
Clinical Information
Syphilis is a disease caused by infection with the spirochete Treponema pallidum. The infection is systemic and the disease is characterized by periods of latency. These features, together with the fact that Treponema pallidum cannot be isolated in culture, mean that serologic techniques play a major role in the diagnosis and follow-up of treatment for syphilis.
Patients with primary or secondary syphilis should be reexamined clinically and serologically 6 months and 12 months following treatment. Typically, rapid plasma reagin titers decrease following successful treatment but this may occur over a period of months to years.
Reference Values
Negative
Cautions
This test should not be used as a primary diagnostic approach for syphilis. For patients with suspected, undiagnosed syphilis, a serum specimen should be submitted for a treponemal-specific antibody test (eg, SYPGR / Syphilis IgG Antibody with Reflex, Serum).
This test cannot be used for testing spinal fluid specimens.
Biological false-positive reactions with cardiolipin-type antigens have been reported in disease such as infectious mononucleosis, leprosy, malaria, lupus erythematosus, vaccinia, and viral pneumonia. Pregnancy, autoimmune diseases, and narcotic addictions may give false-positives. Pinta, yaws, bejel, and other treponemal diseases may also produce positive results with this test.
Day(s) Performed
Monday through Saturday; 9 a.m.
Report Available
Same day/1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86592